The short answer
Do not treat nattokinase as a proven safe add-on or replacement for apixaban. Serious bleeding reports raise concern, but the available cases do not isolate the risk of this exact pair. Review nattokinase with your prescriber; simply taking it at another hour has not been shown to solve the concern.
What this answer covers
Oral nattokinase supplements with adult oral apixaban; nattokinase/serrapeptase mixtures and fermented soy foods are distinct exposures.
- Supplement or preparation
- Nattokinase
- Medication ingredient
- apixaban
What evidence involves apixaban?
One report described kidney injury with bleeding in a man taking apixaban, aspirin and several supplements, including nattokinase/serrapeptase. Kidney deterioration began before the reported supplement use. The authors considered apixaban-related nephropathy, and the contribution of supplements remained unknown. This cannot establish a specific nattokinase interaction or quantify added risk.
Are there reports without apixaban?
A separate 92-year-old woman developed abdominal bleeding after a fall and a ruptured liver cyst while taking an uncertain amount of nattokinase. She was not using anticoagulants or aspirin. The case is a reason for caution, but trauma, the structural bleeding source and uncertain dosing prevent a simple causal conclusion.
Why does the formulation matter?
Nattokinase is an enzyme supplement; a product combined with serrapeptase is not evidence for nattokinase alone. Label activity units, daily serving and other ingredients should be recorded. Neither report establishes the risk from fermented soy food or demonstrates that nattokinase provides the stroke protection expected from prescribed apixaban.
Can I manage the concern by spacing doses?
There is no validated separation interval for this combination. Apixaban has a continuing anticoagulant effect, so a different clock time is not an established safeguard. Ask the prescribing team whether an optional nattokinase product should be used at all. Do not replace apixaban yourself, and seek urgent care for severe or ongoing bleeding.
Evidence and practical considerations
Side effects & toxicity
Do not treat nattokinase as a proven safe add-on or replacement for apixaban. Serious bleeding reports raise concern, but the available cases do not isolate the risk of this exact pair. Review nattokinase with your prescriber; simply taking it at another hour has not been shown to solve the concern.
- Exact scope
- Oral nattokinase supplements with adult oral apixaban; nattokinase/serrapeptase mixtures and fermented soy foods are distinct exposures. with adult oral apixaban tablets
- Medication form and route
- adult oral apixaban tablets
- Timing or duration
- Concurrent oral use. Source-specific durations are recorded in the evidence entries; no unstudied duration threshold or separation schedule is inferred.
What remains uncertain
- Only mixed or supplement-only cases, major confounders, no controlled exact-pair trial and no validated timing intervention. Replacement efficacy was not established.
Factors that may matter: Exact supplement preparation, dose and additional ingredients; Kidney function, age, bleeding history and other antiplatelet or anticoagulant medicines; Current medication formulation and recent supplement start or stop.
Read the supporting source summaries
Source 1: current U.S. regulatory prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People receiving oral apixaban for approved indications.
The label warns of serious bleeding and increased clot risk after premature discontinuation. It explicitly advises avoiding St. John’s wort because combined CYP3A4/P-gp induction reduces apixaban exposure.
How this applies: Establishes the exact medicine’s mechanism, baseline bleeding precautions and formulation/transport limitations; it does not establish this supplement-specific interaction. Exact scope: Oral nattokinase supplements with adult oral apixaban; nattokinase/serrapeptase mixtures and fermented soy foods are distinct exposures.
General antiplatelet-drug precautions do not establish the effect size or causality of each botanical. No herb-specific hourly separation schedule is supplied.
Source 2: original human case report
europepmc.org · Source check Sep 10, 2026
Population: 77-year-old man with chronic kidney disease, atrial fibrillation and coronary disease.
Hematuria, anemia and progressive kidney injury with biopsy findings of anticoagulant-related nephropathy; partial recovery after apixaban cessation.
How this applies: Exact medication co-use occurred with nattokinase/serrapeptase, aspirin and multiple supplements. Kidney injury preceded supplements; not isolated nattokinase causality. Exact scope: Oral nattokinase supplements with adult oral apixaban; nattokinase/serrapeptase mixtures and fermented soy foods are distinct exposures.
Kidney decline preceded recent supplement use; aspirin, chronic disease, serrapeptase and other products confound. This is not a controlled or isolated apixaban/nattokinase interaction.
Source 3: original human case report
europepmc.org · Source check Sep 10, 2026
Population: 92-year-old woman with chronic kidney disease after a fall.
Hemoperitoneum from a ruptured hepatic cyst and death after conservative treatment.
How this applies: Nattokinase-only safety signal after trauma and hepatic cyst rupture; no apixaban exposure. Exact scope: Oral nattokinase supplements with adult oral apixaban; nattokinase/serrapeptase mixtures and fermented soy foods are distinct exposures.
Trauma, structural bleeding source, uncertain dose and declined surgery are major confounders. No apixaban co-use; this is a safety signal, not proof of the pair interaction.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Current labels and targeted original sources assessed; all current available claims adjudicated and consumer article prepared. Uncertainty and indirect evidence retained. Clinical sign-off not recorded. | |
| Research summary published |
Article revision: 8c8aa79a7d5756a8
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.